[go: up one dir, main page]

AU2006906282A0 - Recombinant HCV E2 Glycoprotein for use in HCV Vaccine Treatment - Google Patents

Recombinant HCV E2 Glycoprotein for use in HCV Vaccine Treatment

Info

Publication number
AU2006906282A0
AU2006906282A0 AU2006906282A AU2006906282A AU2006906282A0 AU 2006906282 A0 AU2006906282 A0 AU 2006906282A0 AU 2006906282 A AU2006906282 A AU 2006906282A AU 2006906282 A AU2006906282 A AU 2006906282A AU 2006906282 A0 AU2006906282 A0 AU 2006906282A0
Authority
AU
Australia
Prior art keywords
hcv
glycoprotein
vaccine treatment
recombinant
recombinant hcv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006906282A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Original Assignee
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Filing date
Publication date
Application filed by Macfarlane Burnet Institute for Medical Research and Public Health Ltd filed Critical Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Publication of AU2006906282A0 publication Critical patent/AU2006906282A0/en
Priority to KR1020097005994A priority Critical patent/KR101500017B1/en
Priority to AU2007288129A priority patent/AU2007288129B2/en
Priority to CN200780036968.8A priority patent/CN101563362B/en
Priority to US12/438,657 priority patent/US8535686B2/en
Priority to EP07784854.7A priority patent/EP2061805B1/en
Priority to PCT/AU2007/001221 priority patent/WO2008022401A1/en
Priority to JP2009525853A priority patent/JP5674310B2/en
Priority to CA002661814A priority patent/CA2661814A1/en
Priority to US13/967,059 priority patent/US9598467B2/en
Priority to JP2014185095A priority patent/JP5999524B2/en
Abandoned legal-status Critical Current

Links

AU2006906282A 2006-08-25 2006-11-10 Recombinant HCV E2 Glycoprotein for use in HCV Vaccine Treatment Abandoned AU2006906282A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
CA002661814A CA2661814A1 (en) 2006-08-25 2007-08-24 Recombinant hcv e2 glycoprotein
EP07784854.7A EP2061805B1 (en) 2006-08-25 2007-08-24 Recombinant hcv e2 glycoprotein
AU2007288129A AU2007288129B2 (en) 2006-08-25 2007-08-24 Recombinant HCV E2 glycoprotein
CN200780036968.8A CN101563362B (en) 2006-08-25 2007-08-24 Recombinant HCV E2 glycoprotein
US12/438,657 US8535686B2 (en) 2006-08-25 2007-08-24 Recombinant HCV E2 glycoprotein
KR1020097005994A KR101500017B1 (en) 2006-08-25 2007-08-24 Recombinant HCV E2 glycoprotein
PCT/AU2007/001221 WO2008022401A1 (en) 2006-08-25 2007-08-24 Recombinant hcv e2 glycoprotein
JP2009525853A JP5674310B2 (en) 2006-08-25 2007-08-24 Recombinant HCV E2 glycoprotein
US13/967,059 US9598467B2 (en) 2006-08-25 2013-08-14 Recombinant HCV E2 glycoprotein
JP2014185095A JP5999524B2 (en) 2006-08-25 2014-09-11 Recombinant HCVE2 glycoprotein

Publications (1)

Publication Number Publication Date
AU2006906282A0 true AU2006906282A0 (en) 2006-11-23

Family

ID=

Similar Documents

Publication Publication Date Title
IL195683A0 (en) Recombinant viral vaccine
IL192548A0 (en) Viral hepatitis treatment
IL219040A (en) Cadherin3 (cdh3) derived peptide vaccines
IL232825A0 (en) Fusion peptide therapeutic compositions
ZA200800464B (en) Peptides for use in the treatment of obesity
IL195641A0 (en) Recombinant vaccine against bluetongue virus
ZA200904932B (en) Papillomavirus E2 polypeptide used for vaccination
PL2061485T3 (en) EV576 peptides for use in the treatment of Guillain Barré syndrome
WO2008049974A8 (en) Peptide vaccine for influenza virus
EP2061805A4 (en) RECOMBINANT HCV E2 GLYCOPROTEIN
ZA200808872B (en) Recombinant attenuated clostridium organisms and vaccine
EP1976864A4 (en) Novel peptide and use thereof
EP1874346A4 (en) Recombinant flavivirus vaccines
IL195525A0 (en) Replikin peptides and uses thereof
GB0615635D0 (en) Immunogenic proteins and uses thereof
EP2076544A4 (en) Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same
EP1893233A4 (en) Therapeutic peptides and vaccines
IL213318A0 (en) C1orf59 peptides and vaccines including the same
EP2012829A4 (en) Method for producing viral vaccine and therapeutic peptide antigens
AU2006906282A0 (en) Recombinant HCV E2 Glycoprotein for use in HCV Vaccine Treatment
AU2006906090A0 (en) Recombinant HCV E2 Glycoprotein for use in HCV Vaccine Treatment
PL2032708T3 (en) Recombinant novirhabdoviruses and uses thereof
GB0609121D0 (en) Peptide Therapy
ZA200807552B (en) Recombinant mononegaviral virus vectors
GB0526120D0 (en) Therapeutic peptides